Aristides Capital’s Johnson & Johnson JNJ Stock Holding History

Aristides Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,000	Closed	-$1.17M	–	279
2024 Q2	$1.17M	Buy	+8,000	New	+$1.19M	0.33%	66

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aristides Capital's JNJ Position: Q3 2024 in Review

Aristides Capital sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 8,000 shares — an estimated $1.17M sold.

Aristides Capital first reported a position in JNJ in Q2 2024 and held it in 1 quarter. The position peaked at $1.17M in Q2 2024. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

Aristides Capital reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
Aristides Capital sold 8,000 Johnson & Johnson shares in Q3 2024, an estimated $1.17M.
Aristides Capital first reported a position in Johnson & Johnson in Q2 2024 and held it in 1 quarter.
Aristides Capital's Johnson & Johnson position peaked at $1.17M in Q2 2024.
3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Aristides Capital's 13F filing for Q3 2024, filed 14 Nov 2024.